Cite

HARVARD Citation

    Payne, H. et al. (2018). Preferences for Toxicity Monitoring of Patients on Abiraterone Acetate Plus Prednisone. Clinical oncology. 30 (10), pp. 674-675. [Online]. 
  
Back to record